Health Care & Life Sciences » Biotechnology | Keryx Biopharmaceuticals Inc.

Keryx Biopharmaceuticals Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
55,696.00
85,792.00
200,290.00
111,810.00
93,526.00
Total Accounts Receivable
-
882.00
4,293.00
5,236.00
8,146.00
Inventories
-
7,830.00
41,881.00
12,681.00
28,695.00
Other Current Assets
1,232.00
4,092.00
2,830.00
3,170.00
11,199.00
Total Current Assets
56,928.00
98,596.00
249,294.00
132,897.00
141,566.00
Net Property, Plant & Equipment
349.00
1,532.00
5,083.00
4,211.00
4,521.00
Intangible Assets
3,208.00
3,208.00
3,208.00
3,208.00
3,208.00
Other Assets
281.00
292.00
1,100.00
1,111.00
9,577.00
Total Assets
60,766.00
103,628.00
258,685.00
141,427.00
158,872.00
Accounts Payable
14,004.00
24,146.00
21,322.00
2,225.00
6,474.00
Other Current Liabilities
1,324.00
5,165.00
56,284.00
19,326.00
38,946.00
Total Current Liabilities
15,328.00
29,311.00
77,606.00
21,551.00
45,420.00
Long-Term Debt
-
-
90,773.00
125,000.00
125,000.00
Deferred Taxes
-
700.00
790.00
870.00
635.00
Other Liabilities
38.00
133.00
2,582.00
2,302.00
1,912.00
Total Liabilities
15,366.00
30,144.00
171,751.00
149,723.00
172,967.00
Common Equity (Total)
45,400.00
73,484.00
86,934.00
8,296.00
14,095.00
Total Shareholders' Equity
45,400.00
73,484.00
86,934.00
8,296.00
14,095.00
Total Equity
45,400.00
73,484.00
86,934.00
8,296.00
14,095.00
Liabilities & Shareholders' Equity
60,766.00
103,628.00
258,685.00
141,427.00
158,872.00

About Keryx Biopharmaceuticals

View Profile
Address
12th Floor
Boston Massachusetts 02210
United States
Employees -
Website http://www.keryx.com
Updated 09/14/2018
Keryx Biopharmaceuticals, Inc. engages in the manufacture, development, and commercialization of medicines for use in treating human diseases. Its product is the Auryxia tablet. The company was founded in October 1998 and is headquartered in Boston, MA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.